NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE134114 Query DataSets for GSE134114
Status Public on Jul 27, 2020
Title Effect of NOTCH-γ-secretase inhibitor LY3039478 therapy on patient derived xenograft (PDX) mouse model of intrahepatic cholangiocarcinoma
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Intrahepatic Cholangiocarcinoma (iCCA) is a deadly disease with rising incidence and few treatment options. Recently, aberrant Notch signaling was reported in iCCA carcinogenesis. Specifically, altered expression and/or activation of the receptors Notch1/2 suggests a role for Notch pathway overactivation during iCCA formation and progression. In this study, we examined the effects of Notch inhibition by γ-secretase inhibitor, LY3039478 in human iCCA cell lines and in an excellent patient derived-xenograft (PDX) model. Expression of several Notch pathway components, including NICD, Hes1, and DLL4, were reduced after GSI treatment. Moreover, LY3039478 inhibits cell migration and invasion while in GSI-treated mice, tumor growth was delayed compared to vehicle and chemotherapy. These results support the notion that Notch inhibition by GSI may reduce in vivo tumorigenesis. In addition, GSI reduces in PDX model VEGFA and MMP13 involved in capillary tube formation and tumor progression. Here, we therefore show a link between the efficacy of Notch inhibition and the tumor microenvironment through LY3039478 that slows tumor progression compared to control mice blocking angiogenesis via MMP13 downregulation.
We used microarray technology to understand the molecular mechanisms affected by LY3039478. Cholangiocarcinoma PDX model was employed in this analysis.
 
Overall design Expression profiling of patient-derived xenografts (PDX) from patients with intrahepatic cholangiocarcinoma after and before LY3039478 treatment. Moreover, we also analyzed the of the original tumor mass and PDX tissue comparing them to the surrounding normal mass of patient.
 
Contributor(s) Mancarella S, Serino G, Giannelli G
Citation(s) 32042099
Submission date Jul 10, 2019
Last update date Jul 27, 2020
Contact name Grazia Serino
E-mail(s) grazia.serino@irccsdebellis.it
Organization name National Institute of Gastroenterology “S. de Bellis”, Research Hospital
Street address Via Turi, 27
City Castellana Grotte (BA)
ZIP/Postal code 70013
Country Italy
 
Platforms (1)
GPL17586 [HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version]
Samples (11)
GSM3937463 Patient Tumor tissue
GSM3937464 Patient Peritumoral tissue
GSM3937465 Human mass implanted in PDX
Relations
BioProject PRJNA553805

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE134114_RAW.tar 339.6 Mb (http)(custom) TAR (of CEL, CHP)
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap